Vasoactive intestinal peptide ameliorates renal injury in a pristane-induced lupus mouse model by modulating Th17/Treg balance.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Vasoactive intestinal peptide ameliorates renal injury in a pristane-induced lupus mouse model by modulating Th17/Treg balance.
- Published In:
- BMC nephrology, 20(1), 350 (2019)
- Authors:
- Fu, Dongdong, Senouthai, Soulixay, Wang, Junjie, You, Yanwu
- Database ID:
- RPEP-04172
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-04172APA
Fu, Dongdong; Senouthai, Soulixay; Wang, Junjie; You, Yanwu. (2019). Vasoactive intestinal peptide ameliorates renal injury in a pristane-induced lupus mouse model by modulating Th17/Treg balance.. BMC nephrology, 20(1), 350. https://doi.org/10.1186/s12882-019-1548-y
MLA
Fu, Dongdong, et al. "Vasoactive intestinal peptide ameliorates renal injury in a pristane-induced lupus mouse model by modulating Th17/Treg balance.." BMC nephrology, 2019. https://doi.org/10.1186/s12882-019-1548-y
RethinkPeptides
RethinkPeptides Research Database. "Vasoactive intestinal peptide ameliorates renal injury in a ..." RPEP-04172. Retrieved from https://rethinkpeptides.com/research/fu-2019-vasoactive-intestinal-peptide-ameliorates
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.